Novartis Faces Legal Hurdle as Court Denies Dismissal in Trade Secret Dispute with Hedge Fund

In a recent judicial development, the pharmaceutical giant Novartis has been dealt a setback in a legal battle involving trade secret allegations. A New York federal judge denied Novartis’ motion to dismiss a lawsuit brought by an investment management firm. This firm has accused the company, among others, of conspiring with its former chief investment…

Read More

Judge Albright Advocates for Conciseness in Patent Trials Amid USPTO Reforms

During a recent address at the US Inventor conference, former U.S. District Judge Alan Albright offered a provocative suggestion: attorneys should be less verbose during jury trials. Albright, known for his time overseeing significant patent cases, emphasized that brevity and clarity could lead to more effective communication with jurors. This observation comes amid notable discussions…

Read More

Federal Judge Rules Against Liquidia in Pulmonary Hypertension Patent Dispute

In a significant development for the pharmaceutical industry, a Delaware federal judge has determined that Liquidia Technologies infringed upon a patent that protects methods for treating pulmonary hypertension associated with interstitial lung disease. This conclusion stems from Liquidia’s attempts to secure approval for Yutrepia, a drug designed to address this medical condition. The ruling reinforces…

Read More

Federal Circuit Ruling on Scientific Impossibility Highlights Patent Enablement Challenges for Samsung

In a significant ruling on patent validity, the Federal Circuit affirmed a decision in favor of Samsung Electronics Co. Ltd., determining that certain wireless communications patent claims were invalid due to their reliance on “scientific impossibility.” These claims, central to a case brought against the tech giant, were found to lack the necessary enablement for…

Read More

Court Halts Biosimilar Launch: Janssen Biotech Wins Temporary Restraining Order Against Accord BioPharma

In a recent development from the U.S. District Court in Delaware, a temporary restraining order has been granted to Janssen Biotech, effectively stalling Accord BioPharma’s efforts to produce a biosimilar to its flagship arthritis medication, Simponi. This decision is pivotal as it underscores the ongoing battles within the pharmaceutical industry over patent rights and the…

Read More

Gibson Dunn Strengthens Dallas IP Team with Key Hires from McKool Smith Amid Patent Litigation Demand

Gibson Dunn LLP has bolstered its intellectual property practice in Dallas with the addition of two seasoned litigators from McKool Smith. The move was announced on Thursday as the global law firm seeks to expand its footprint in patent litigation. The new partners bring extensive experience in handling complex cases, aiming to enhance Gibson Dunn’s…

Read More

Gibson Dunn Strengthens Dallas Presence with Strategic Hire of Prominent Patent Litigators

In a strategic move to bolster its intellectual property capabilities in Texas, Gibson, Dunn & Crutcher LLP has successfully recruited two prominent patent litigators from the boutique litigation powerhouse McKool Smith. The addition of partners Brett Pursley and Kyle Kent marks a significant expansion for Gibson Dunn’s Dallas office, reinforcing their commitment to growing their…

Read More

Federal Judge Overturns $22.7 Million Jury Verdict in Gogo Patent Dispute Citing Flawed Damages Calculation

In a significant decision by the US District Court for the District of Delaware, a federal judge has vacated a jury verdict requiring Gogo Business Aviation to pay approximately $22.7 million in damages for patent infringement. The case revolved around alleged infringements of four patents owned by SmartSky Networks, a competing in-flight Wi-Fi provider. However,…

Read More

Eli Lilly Loses Federal Circuit Bid as Teva’s $177 Million Patent Win Stands

The Federal Circuit has delivered a significant ruling against Eli Lilly & Co., denying the pharmaceutical giant’s request for a full-court review concerning a jury verdict that awarded Teva Pharmaceuticals $177 million for patent infringement. The verdict centered on Eli Lilly’s alleged infringement of Teva’s patents related to a headache medication. This decision upholds an…

Read More

PTAB Ruling Undermines Stratasys Patents, Impacting $27.6 Million Verdict

The recent ruling by the Patent Trial and Appeal Board (PTAB) has stirred significant attention in the legal landscape, as it invalidated most claims challenged in three Stratasys Inc. 3D printer patents. This decision affects a substantial portion of Stratasys’ $27.6 million infringement victory obtained in Texas, specifically undermining $2.8 million of the awarded damages….

Read More

Federal Circuit Rejects ParkerVision’s Appeal in Ongoing Patent Dispute with Qualcomm, Emphasizes Court’s Hesitance on Piecemeal Litigation

The Federal Circuit recently declined to consider an appeal from ParkerVision in its ongoing patent litigation against Qualcomm. The court determined it could not address ParkerVision’s challenge to a lower court’s interpretation of specific patent claims while other claims from the same patent remain unsettled. This decision underscores a judicial hesitance to engage in piecemeal…

Read More

Federal Circuit Challenges Georgia Court on Epic Tech Patent Sanction Decision

The Federal Circuit has mandated that a Georgia federal judge must justify the decision not to issue sanctions against Epic Tech LLC in an intellectual property lawsuit against Pen-Tech Associates Inc., citing significant indicators of invalidity in the asserted patent. The appellate court’s intervention underscores the judiciary’s ongoing scrutiny over the enforcement of questionable patents,…

Read More

Judge Overturns $14 Million Patent Verdict Against Anker, Citing Inadequate Apportionment Evidence

In a recent development within the legal landscape of intellectual property, a federal judge in Delaware has nullified a $14 million jury verdict against Anker Innovations, a prominent electronics company headquartered in Hong Kong. This decision came as a result of the plaintiff, Fundamental Innovation Systems International LLC, failing to adequately demonstrate the apportionment aspect…

Read More

ParkerVision’s Bid for New Judge in Qualcomm Patent Dispute Denied by U.S. Court

ParkerVision Inc.’s attempt to secure a new judge in its ongoing patent litigation with Qualcomm Inc. has hit a roadblock, as a U.S. magistrate judge decided against transferring the case to another district judge. This decision comes amidst ParkerVision’s efforts to maintain its legal footing in a complex battle over wireless technology patents. The request…

Read More

New Jersey Court Advances Antitrust Case Against Celgene and Partners Over Revlimid Pricing Practices

In a notable development within the pharmaceutical industry, a New Jersey federal judge has denied motions to dismiss a complex antitrust multidistrict litigation (MDL) involving Celgene Corp.’s cancer medication Revlimid. The litigation accuses Bristol-Myers Squibb, Natco Pharma, AbbVie, and other pharmaceutical companies of engaging in “pay-for-delay” agreements, which allegedly delayed the entry of generic competitors…

Read More

Disney’s Antitrust Battle with InterDigital Over Patent Licensing on Temporary Hold

In a significant development in the legal realm, Disney’s ongoing antitrust litigation against InterDigital has experienced a temporary halt. The pause comes after InterDigital successfully petitioned a Delaware federal judge to suspend proceedings. Disney’s suit accuses InterDigital of failing to provide reasonable licensing terms for essential patents related to video streaming technology. The legal confrontation…

Read More

Nvidia Faces Legal Battle Over Patent Dispute in Texas Federal Court

Nvidia Corporation, known for its cutting-edge technology and substantial market influence, is currently embroiled in legal proceedings regarding alleged patent infringement. The lawsuit, filed on Tuesday in a Texas federal court, claims that Nvidia’s data centers have been utilizing technology covered by five networking patents previously held by Avaya Inc. These patents underline critical aspects…

Read More

Wisconsin Judge Invalidates Eyeglass Lens Patents, Citing Prior Art Precedent

In the ongoing legal battle over eyeglass lens patents, a Wisconsin federal judge has once again invalidated two patents, asserting that a prior patent disclosed the claimed methods of these patents. This decision comes after a previous ruling was nullified by the Federal Circuit, demonstrating the complexity and intricacies involved in patent litigation. The judge’s…

Read More